These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17892526)

  • 1. Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia.
    Thumshirn M; Fruehauf H; Stutz B; Tougas G; Salter J; Fried M
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1399-407. PubMed ID: 17892526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
    Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
    Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia.
    Tack J; Janssen P; Bisschops R; Vos R; Phillips T; Tougas G
    Neurogastroenterol Motil; 2011 Feb; 23(2):e32-9. PubMed ID: 20979591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
    Vakil N; Laine L; Talley NJ; Zakko SF; Tack J; Chey WD; Kralstein J; Earnest DL; Ligozio G; Cohard-Radice M
    Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neostigmine-induced postprandial phasic contractility in the proximal stomach and dyspepsia-like symptoms in healthy volunteers.
    Di Stefano M; Vos R; Klersy C; Lee KJ; Janssens J; Tack J
    Am J Gastroenterol; 2006 Dec; 101(12):2797-804. PubMed ID: 17227525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
    Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO
    Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
    Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
    Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses.
    Mearin F; Balboa A; Zárate N; Cucala M; Malagelada JR
    Am J Gastroenterol; 1999 Jan; 94(1):116-25. PubMed ID: 9934741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
    Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.
    Talley NJ; Camilleri M; Burton D; Thomforde G; Koch K; Rucker MJ; Peterson J; Zinsmeister AR; Earnest DL
    Aliment Pharmacol Ther; 2006 Sep; 24(5):859-67. PubMed ID: 16918891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT4 antagonist R216073 does not affect gastric motor and sensory function in patients with functional dyspepsia.
    Van Lelyveld N; Ter Linde J; Baron A; Mundt M; Wajs E; Samsom M
    Aliment Pharmacol Ther; 2006 Aug; 24(4):669-77. PubMed ID: 16827813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant enhancement of esophageal pre-epithelial defense by tegaserod: implications for an esophagoprotective effect.
    Majewski M; Jaworski T; Sarosiek I; Sostarich S; Roeser K; Edlavitch SA; Kralstein J; Wallner G; McCallum RW; Sarosiek J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):430-8. PubMed ID: 17445751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
    Tougas G; Earnest DL; Chen Y; Vanderkoy C; Rojavin M
    Aliment Pharmacol Ther; 2005 Jul; 22(1):59-65. PubMed ID: 15963081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
    Morganroth J; Rüegg PC; Dunger-Baldauf C; Appel-Dingemanse S; Bliesath H; Lefkowitz M
    Am J Gastroenterol; 2002 Sep; 97(9):2321-7. PubMed ID: 12358251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of tegaserod on proximal gastric tone and on the perception of gastric distension.
    Tack J; Vos R; Janssens J; Salter J; Jauffret S; Vandeplassche G
    Aliment Pharmacol Ther; 2003 Nov; 18(10):1031-7. PubMed ID: 14616170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sildenafil on gastric sensorimotor function in humans.
    Sarnelli G; Sifrim D; Janssens J; Tack J
    Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G988-92. PubMed ID: 15475488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal activation by sham feeding improves gastric motility in functional dyspepsia.
    Lunding JA; Nordström LM; Haukelid AO; Gilja OH; Berstad A; Hausken T
    Neurogastroenterol Motil; 2008 Jun; 20(6):618-24. PubMed ID: 18248581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of tegaserod on oesophageal function and bolus transport in healthy volunteers: studies using concurrent high-resolution manometry and videofluoroscopy.
    Fox M; Menne D; Stutz B; Fried M; Schwizer W
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1017-27. PubMed ID: 16984495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.